The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

The cuts would have impacted Central Florida programs, including about $1 million worth of initiatives in Orange County.

The three-year pilot program did not deliver the results hoped for, the health minister said. It had allowed drug users to ...

The program is available to anyone regardless of age, income or whether or not they have insurance. There is no cost for the ...

FDA delays drug reviews for two priority voucher drugs amid safety and efficacy concerns, extending timelines for Sanofi and Disc Medicine products.

South Dakota will expand a specialty program for people facing drug charges, a move spurred by a decision last year to lessen ...

Let your voice be heard!Today we will be running a story on the SAFE Yakima Valley receiving SAMHSA Federal funding again.We ...

The number of overdose deaths in Pennsylvania is down to six per day, down from about 13 per day in 2023. At a roundtable in ...

Half of the net proceeds will go to Jazz; it remains unclear who will get the remaining sum. Jazz did not reveal the buyer of the voucher.

The plan, released the same day Affordable Care Act open enrollment ends in most states, offered few details and largely ...

Target action dates for drugs sponsored by Sanofi, Boehringer Ingelheim and Disc Medicine have also been pushed back despite ...

Trump has long been dogged by his lack of a comprehensive health care plan as he and Republicans have sought to unwind former ...